{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T04:10:05Z","timestamp":1792469405054,"version":"4.5.0"},"reference-count":163,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100007658","name":"Crohn's and Colitis Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007658","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000035","name":"Institute of Nutrition, Metabolism and Diabetes","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000035","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000066","name":"Canadian Child Health Clinician Scientist Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000066","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000149","name":"Canadian Association of Gastroenterology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000149","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gastrojournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterology"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1053\/j.gastro.2021.04.034","type":"journal-article","created":{"date-parts":[[2021,7,29]],"date-time":"2021-07-29T14:10:52Z","timestamp":1627567852000},"page":"681-700","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Canadian Association of Gastroenterology Clinical Practice Guideline for Immunizations in Patients With Inflammatory Bowel Disease (IBD)\u2014Part 2: Inactivated Vaccines"],"prefix":"10.1053","volume":"161","author":[{"given":"Jennifer L.","family":"Jones","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frances","family":"Tse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew W.","family":"Carroll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer C.","family":"deBruyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelly A.","family":"McNeil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Pham-Huy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia H.","family":"Seow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa L.","family":"Barrett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talat","family":"Bessissow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Carman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gil Y.","family":"Melmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Otto G.","family":"Vanderkooi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John K.","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric I.","family":"Benchimol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.gastro.2021.04.034_bib1","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1111\/j.1572-0241.2006.00646.x","article-title":"Patients with inflammatory bowel disease are at risk for vaccine-preventable illnesses","volume":"101","author":"Melmed","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2021.04.034_bib2","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s10620-010-1329-8","article-title":"Are primary care providers uncomfortable providing routine preventive care for inflammatory bowel disease patients?","volume":"56","author":"Selby","year":"2011","journal-title":"Dig Dis Sci"},{"key":"10.1053\/j.gastro.2021.04.034_bib3","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/01.MIB.0000437737.68841.87","article-title":"Immunization rates and vaccine beliefs among patients with inflammatory bowel disease: an opportunity for improvement","volume":"20","author":"Wasan","year":"2014","journal-title":"Inflamm Bowel Dis"},{"key":"10.1053\/j.gastro.2021.04.034_bib4","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/j.vaccine.2011.11.109","article-title":"Are immunosuppressive medications associated with decreased responses to routine immunizations? A systematic review","volume":"30","author":"Agarwal","year":"2012","journal-title":"Vaccine"},{"key":"10.1053\/j.gastro.2021.04.034_bib5","doi-asserted-by":"crossref","first-page":"11273","DOI":"10.3748\/wjg.v21.i40.11273","article-title":"Immunogenicity and mechanisms impairing the response to vaccines in inflammatory bowel disease","volume":"21","author":"Mar\u00edn","year":"2015","journal-title":"World J Gastroenterol"},{"key":"10.1053\/j.gastro.2021.04.034_bib6","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1053\/j.gastro.2020.12.079","article-title":"Canadian Association of Gastroenterology Clinical Practice Guideline for Immunizations in Patients With Inflammatory Bowel Disease (IBD)\u2014Part 1: live vaccines","volume":"161","author":"Benchimol","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2021.04.034_bib7","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"10.1053\/j.gastro.2021.04.034_bib8","doi-asserted-by":"crossref","first-page":"525","DOI":"10.7326\/0003-4819-156-7-201204030-00009","article-title":"Guidelines International Network: toward international standards for clinical practice guidelines","volume":"156","author":"Qaseem","year":"2012","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.gastro.2021.04.034_bib9","series-title":"Clinical practice Guidelines We Can Trust","author":"Graham","year":"2011"},{"key":"10.1053\/j.gastro.2021.04.034_bib10","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2147\/CEG.S42514","article-title":"Hospitalizations for vaccine preventable pneumonias in patients with inflammatory bowel disease: a 6-year analysis of the Nationwide Inpatient Sample","volume":"6","author":"Stobaugh","year":"2013","journal-title":"Clin Exp Gastroenterol"},{"key":"10.1053\/j.gastro.2021.04.034_bib11","series-title":"Conjugate vaccines for preventing Haemophilus influenzae type B infections","first-page":"CD001729","author":"Swingler","year":"2007"},{"key":"10.1053\/j.gastro.2021.04.034_bib14","first-page":"1094","article-title":"Economic evaluations of Haemophilus influenzae type b (Hib) vaccine: a systematic review","volume":"20","author":"Chongmelaxme","year":"2017","journal-title":"J\u00a0Med Econ"},{"key":"10.1053\/j.gastro.2021.04.034_bib15","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/ibd.21688","article-title":"Normal response to vaccines in inflammatory bowel disease patients treated with thiopurines","volume":"18","author":"Dotan","year":"2012","journal-title":"Inflamm Bowel Dis"},{"key":"10.1053\/j.gastro.2021.04.034_bib16","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1093\/ibd\/izy249","article-title":"Herpes zoster infection and herpes zoster vaccination in a population-based sample of persons with IBD: is there still an unmet need?","volume":"25","author":"Nugent","year":"2019","journal-title":"Inflamm Bowel Dis"},{"key":"10.1053\/j.gastro.2021.04.034_bib17","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1016\/j.cgh.2017.12.052","article-title":"Overall and comparative risk of herpes zoster with pharmacotherapy for inflammatory bowel diseases: a nationwide cohort study","volume":"16","author":"Khan","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2021.04.034_bib18","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1016\/j.cgh.2018.05.024","article-title":"Increased risk of herpes zoster infection in patients with inflammatory bowel diseases in Korea","volume":"16","author":"Chang","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2021.04.034_bib19","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1002\/art.39670","article-title":"Risk of herpes zoster in autoimmune and inflammatory diseases: implications for vaccination","volume":"68","author":"Yun","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"10.1053\/j.gastro.2021.04.034_bib20","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/ijcp.12508","article-title":"Increased risk of varicella zoster virus infection in inflammatory bowel disease in an Asian population: a nationwide population-based cohort study","volume":"69","author":"Tsai","year":"2015","journal-title":"Int J Clin Pract"},{"key":"10.1053\/j.gastro.2021.04.034_bib21","doi-asserted-by":"crossref","first-page":"g2911","DOI":"10.1136\/bmj.g2911","article-title":"Quantification of risk factors for herpes zoster: population based case-control study","volume":"348","author":"Forbes","year":"2014","journal-title":"BMJ"},{"key":"10.1053\/j.gastro.2021.04.034_bib22","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/apt.12182","article-title":"Increased risk of herpes zoster among 108 604 patients with inflammatory bowel disease","volume":"37","author":"Long","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2021.04.034_bib23","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1038\/ajg.2009.322","article-title":"Adverse events associated with common therapy regimens for moderate-to-severe Crohn's disease","volume":"104","author":"Marehbian","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2021.04.034_bib24","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1016\/j.cgh.2006.09.019","article-title":"Incidence and risk factors for herpes zoster among patients with inflammatory bowel disease","volume":"4","author":"Gupta","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2021.04.034_bib25","doi-asserted-by":"crossref","first-page":"ofw205","DOI":"10.1093\/ofid\/ofw205","article-title":"Risk of herpes zoster in individuals on biologics, disease-modifying antirheumatic drugs, and\/or corticosteroids for autoimmune diseases: a systematic review and meta-analysis","volume":"3","author":"Marra","year":"2016","journal-title":"Open Forum Infect Dis"},{"key":"10.1053\/j.gastro.2021.04.034_bib26","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1093\/ibd\/izy131","article-title":"Herpes zoster infection in patients with ulcerative colitis receiving tofacitinib","volume":"24","author":"Winthrop","year":"2018","journal-title":"Inflamm Bowel Dis"},{"key":"10.1053\/j.gastro.2021.04.034_bib27","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1136\/gutjnl-2015-311079","article-title":"The safety of vedolizumab for ulcerative colitis and Crohn's disease","volume":"66","author":"Colombel","year":"2017","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2021.04.034_bib28","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/ecco-jcc\/jjz110","article-title":"IM-UNITI: 3 year efficacy, safety, and immunogenicity of ustekinumab treatment of Crohn's disease","volume":"14","author":"Hanauer","year":"2020","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1053\/j.gastro.2021.04.034_bib29","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/j.cgh.2018.10.016","article-title":"Efficacy of live attenuated herpes zoster vaccine in patients with inflammatory bowel diseases","volume":"17","author":"Khan","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2021.04.034_bib30","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1001\/jama.2012.7304","article-title":"Association between vaccination for herpes zoster and risk of herpes zoster infection among older patients with selected immune-mediated diseases","volume":"308","author":"Zhang","year":"2012","journal-title":"JAMA"},{"key":"10.1053\/j.gastro.2021.04.034_bib31","doi-asserted-by":"crossref","first-page":"R174","DOI":"10.1186\/ar3497","article-title":"The use, safety, and effectiveness of herpes zoster vaccination in individuals with inflammatory and autoimmune diseases: a longitudinal observational study","volume":"13","author":"Zhang","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"10.1053\/j.gastro.2021.04.034_bib32","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1097\/MIB.0000000000000743","article-title":"Herpes zoster vaccine response in inflammatory bowel disease patients on low-dose immunosuppression","volume":"22","author":"Wasan","year":"2016","journal-title":"Inflamm Bowel Dis"},{"key":"10.1053\/j.gastro.2021.04.034_bib33","doi-asserted-by":"crossref","first-page":"103","DOI":"10.15585\/mmwr.mm6703a5","article-title":"Recommendations of the Advisory Committee on Immunization Practices for use of herpes zoster vaccines","volume":"67","author":"Dooling","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1053\/j.gastro.2021.04.034_bib34","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1056\/NEJMoa1501184","article-title":"Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults","volume":"372","author":"Lal","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1053\/j.gastro.2021.04.034_bib35","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.2165\/11314000-000000000-00000","article-title":"Willingness to pay for a QALY based on community member and patient preferences for temporary health states associated with herpes zoster","volume":"27","author":"Lieu","year":"2009","journal-title":"Pharmacoeconomics"},{"key":"10.1053\/j.gastro.2021.04.034_bib36","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1016\/j.vaccine.2017.04.014","article-title":"Vaccine preferences and acceptance of older adults","volume":"35","author":"Eilers","year":"2017","journal-title":"Vaccine"},{"key":"10.1053\/j.gastro.2021.04.034_bib37","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s40258-019-00491-6","article-title":"Public health impact and cost-effectiveness of non-live adjuvanted recombinant zoster vaccine in Canadian adults","volume":"17","author":"McGirr","year":"2019","journal-title":"Appl Health Econ Health Policy"},{"key":"10.1053\/j.gastro.2021.04.034_bib38","doi-asserted-by":"crossref","first-page":"380","DOI":"10.7326\/M18-2347","article-title":"A\u00a0cost-effectiveness analysis of vaccination for prevention of herpes zoster and related complications: input for national recommendations","volume":"170","author":"Prosser","year":"2019","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.gastro.2021.04.034_bib39","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/MEG.0000000000000838","article-title":"Prevalence of hepatitis B and C and factors for infection and nonimmune in inflammatory bowel disease patients in China","volume":"29","author":"Chen","year":"2017","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2021.04.034_bib40","doi-asserted-by":"crossref","first-page":"4139656","DOI":"10.1155\/2017\/4139656","article-title":"Serology of viral infections and tuberculosis screening in an IBD population referred to a tertiary centre of southern Italy","volume":"2017","author":"Ardesia","year":"2017","journal-title":"Gastroenterol Res Pract"},{"key":"10.1053\/j.gastro.2021.04.034_bib41","first-page":"8078","article-title":"Prevalence and influences of hepatitis B virus infection on inflammatory bowel disease: a retrospective study in southern China","volume":"8","author":"He","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"10.1053\/j.gastro.2021.04.034_bib42","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.crohns.2013.08.017","article-title":"Prevalence and factors related to hepatitis B and C infection in inflammatory bowel disease patients in China: a retrospective study","volume":"8","author":"Huang","year":"2014","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1053\/j.gastro.2021.04.034_bib43","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1097\/01.mcg.0000436435.75392.23","article-title":"Prevalence of hepatitis-B viral markers in patients with inflammatory bowel disease in a hepatitis-B-endemic area: inadequate protective antibody levels in young patients","volume":"48","author":"Kim","year":"2014","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1053\/j.gastro.2021.04.034_bib44","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1002\/ibd.21147","article-title":"Prevalence of hepatitis B and C and risk factors for nonvaccination in inflammatory bowel disease patients in Northeast France","volume":"16","author":"Chevaux","year":"2010","journal-title":"Inflamm Bowel Dis"},{"key":"10.1053\/j.gastro.2021.04.034_bib45","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.crohns.2010.03.001","article-title":"Inflammatory bowel disease and hepatitis B and C in Western Balkans: a referral centre study and review of the literature","volume":"4","author":"Katsanos","year":"2010","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1053\/j.gastro.2021.04.034_bib46","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/ajg.2008.4","article-title":"Prevalence and factors related to hepatitis B and C in inflammatory bowel disease patients in Spain: a nationwide, multicenter study","volume":"104","author":"Loras","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2021.04.034_bib47","doi-asserted-by":"crossref","first-page":"3201","DOI":"10.3748\/wjg.14.3201","article-title":"Hepatitis B virus prevalence and transmission risk factors in inflammatory bowel disease patients at Clementino Fraga Filho University Hospital","volume":"14","author":"Tolentino","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1053\/j.gastro.2021.04.034_bib48","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/00054725-200111000-00002","article-title":"Hepatitis B and C virus infection in Crohn's disease","volume":"7","author":"Biancone","year":"2001","journal-title":"Inflamm Bowel Dis"},{"key":"10.1053\/j.gastro.2021.04.034_bib49","first-page":"CD004790","article-title":"Hepatitis B immunisation for newborn infants of hepatitis B surface antigen-positive mothers","author":"Lee","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1053\/j.gastro.2021.04.034_bib50","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/hep.27048","article-title":"Incomplete hepatitis B immunization, maternal carrier status, and increased risk of liver diseases: a 20-year cohort study of 3.8 million vaccinees","volume":"60","author":"Chien","year":"2014","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2021.04.034_bib51","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1001\/jama.2013.276701","article-title":"Thirty-year outcomes of the national hepatitis B immunization program in Taiwan","volume":"310","author":"Chiang","year":"2013","journal-title":"JAMA"},{"key":"10.1053\/j.gastro.2021.04.034_bib52","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1093\/ibd\/izy366","article-title":"Serologic status of routine childhood vaccines, cytomegalovirus, and Epstein-Barr virus in children with inflammatory bowel disease","volume":"25","author":"deBruyn","year":"2019","journal-title":"Inflamm Bowel Dis"},{"key":"10.1053\/j.gastro.2021.04.034_bib53","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1097\/MPG.0000000000001580","article-title":"Incidence of low seroimmunity to hepatitis B virus in children with inflammatory bowel disease","volume":"65","author":"Watts","year":"2017","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1053\/j.gastro.2021.04.034_bib54","doi-asserted-by":"crossref","first-page":"7644","DOI":"10.3748\/wjg.v23.i42.7644","article-title":"Vaccinations in immunosuppressive-dependent pediatric inflammatory bowel disease","volume":"23","author":"Nguyen","year":"2017","journal-title":"World J Gastroenterol"},{"key":"10.1053\/j.gastro.2021.04.034_bib55","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/ajg.2011.295","article-title":"Hepatitis B immunity and response to booster vaccination in children with inflammatory bowel disease treated with infliximab","volume":"107","author":"Moses","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2021.04.034_bib56","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/MPG.0b013e31827dd87d","article-title":"Immunogenecity of hepatitis A and B vaccination in pediatric patients with inflammatory bowel disease","volume":"56","author":"Urganci","year":"2013","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1053\/j.gastro.2021.04.034_bib57","first-page":"1709","article-title":"Use of hepatitis B vaccination for adults with diabetes mellitus: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"60","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1053\/j.gastro.2021.04.034_bib58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6701a1","article-title":"Prevention of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices","volume":"67","author":"Schillie","year":"2018","journal-title":"MMWR Recomm Rep"},{"key":"10.1053\/j.gastro.2021.04.034_bib59","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1097\/MIB.0b013e31827febe9","article-title":"Kinetics of anti-hepatitis B surface antigen titers after hepatitis B vaccination in patients with inflammatory bowel disease","volume":"19","author":"Gisbert","year":"2013","journal-title":"Inflamm Bowel Dis"},{"key":"10.1053\/j.gastro.2021.04.034_bib60","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1056\/NEJM198408233110803","article-title":"Hepatitis B vaccine in patients receiving hemodialysis. Immunogenicity and efficacy","volume":"311","author":"Stevens","year":"1984","journal-title":"N\u00a0Engl J Med"},{"key":"10.1053\/j.gastro.2021.04.034_bib61","doi-asserted-by":"crossref","first-page":"298","DOI":"10.7326\/0003-4819-118-4-199302150-00009","article-title":"A\u00a0reappraisal of hepatitis B virus vaccination strategies using cost-effectiveness analysis","volume":"118","author":"Bloom","year":"1993","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.gastro.2021.04.034_bib62","first-page":"278","article-title":"Acceptability of universal hepatitis B vaccination among school pupils and parents","volume":"7","author":"Hinds","year":"2004","journal-title":"Commun Dis Public Health"},{"key":"10.1053\/j.gastro.2021.04.034_bib64","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1016\/j.vaccine.2017.03.080","article-title":"Immune response to hepatitis B vaccination among people with inflammatory bowel diseases: a systematic review and meta-analysis","volume":"35","author":"Jiang","year":"2017","journal-title":"Vaccine"},{"key":"10.1053\/j.gastro.2021.04.034_bib65","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1016\/j.crohns.2014.06.009","article-title":"Impact of surveillance of hepatitis B and hepatitis C in patients with inflammatory bowel disease under anti-TNF therapies: multicenter prospective observational study (REPENTINA 3)","volume":"8","author":"Loras","year":"2014","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1053\/j.gastro.2021.04.034_bib66","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1136\/gutjnl-2014-307127","article-title":"Vedolizumab affects antibody responses to immunisation selectively in the gastrointestinal tract: randomised controlled trial results","volume":"64","author":"Wyant","year":"2015","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2021.04.034_bib67","doi-asserted-by":"crossref","first-page":"14S","DOI":"10.1016\/0002-9343(89)90525-1","article-title":"Summary of safety and efficacy data on a yeast-derived hepatitis B vaccine","volume":"87","author":"Andre","year":"1989","journal-title":"Am J Med"},{"key":"10.1053\/j.gastro.2021.04.034_bib68","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1053\/j.gastro.2017.02.009","article-title":"Hepatitis B reactivation associated with immune suppressive and biological modifier therapies: current concepts, management strategies, and future directions","volume":"152","author":"Loomba","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2021.04.034_bib69","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1136\/gut.2010.208413","article-title":"Liver dysfunction related to hepatitis B and C in patients with inflammatory bowel disease treated with immunosuppressive therapy","volume":"59","author":"Loras","year":"2010","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2021.04.034_bib70","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1093\/clinids\/20.4.992","article-title":"Risks of chronicity following acute hepatitis B virus infection: a review","volume":"20","author":"Hyams","year":"1995","journal-title":"Clin Infect Dis"},{"key":"10.1053\/j.gastro.2021.04.034_bib71","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2337\/dc12-0759","article-title":"Cost-effectiveness\u00a0of hepatitis B vaccination in adults with diagnosed diabetes","volume":"36","author":"Hoerger","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1053\/j.gastro.2021.04.034_bib72","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1038\/ajg.2012.79","article-title":"Efficacy of hepatitis B vaccination and revaccination and factors impacting on response in patients with inflammatory bowel disease","volume":"107","author":"Gisbert","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2021.04.034_bib73","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/jgh.12712","article-title":"Immunogenicity of hepatitis B vaccine in patients with inflammatory bowel disease and the benefits of revaccination","volume":"30","author":"Cossio-Gil","year":"2015","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2021.04.034_bib74","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1016\/j.vaccine.2013.04.059","article-title":"Factors predicting response to hepatitis B vaccination in patients with inflammatory bowel disease","volume":"31","author":"Sempere","year":"2013","journal-title":"Vaccine"},{"key":"10.1053\/j.gastro.2021.04.034_bib75","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1007\/s10620-019-05595-6","article-title":"Improved antibody response to three additional hepatitis B vaccine doses following primary vaccination failure in patients with inflammatory bowel disease","volume":"64","author":"Pratt","year":"2019","journal-title":"Dig Dis Sci"},{"key":"10.1053\/j.gastro.2021.04.034_bib76","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1111\/j.1365-2036.2012.05110.x","article-title":"Comparison of the effectiveness of two protocols for vaccination (standard and double dosage) against hepatitis B virus in patients with inflammatory bowel disease","volume":"35","author":"Gisbert","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2021.04.034_bib77","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1080\/21645515.2019.1574151","article-title":"High dose hepatitis B vaccine is not effective in patients using immunomodulatory drugs: a pilot study","volume":"15","author":"Haykir Solay","year":"2019","journal-title":"Hum Vaccin Immunother"},{"key":"10.1053\/j.gastro.2021.04.034_bib78","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/ibd\/izy243","article-title":"Increased risk of influenza and influenza-related complications among 140,480 patients with inflammatory bowel disease","volume":"25","author":"Tinsley","year":"2019","journal-title":"Inflamm Bowel Dis"},{"key":"10.1053\/j.gastro.2021.04.034_bib79","first-page":"CD004879","article-title":"Vaccines for preventing influenza in healthy children","volume":"2","author":"Jefferson","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1053\/j.gastro.2021.04.034_bib80","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/ibd.21706","article-title":"Immunogenicity and safety of influenza vaccination in children with inflammatory bowel disease","volume":"18","author":"deBruyn","year":"2012","journal-title":"Inflamm Bowel Dis"},{"key":"10.1053\/j.gastro.2021.04.034_bib81","first-page":"CR433","article-title":"Immunization against influenza during the 2005\/2006 epidemic season and the humoral response in children with diagnosed inflammatory bowel disease (IBD)","volume":"16","author":"Romanowska","year":"2010","journal-title":"Med Sci Monit"},{"key":"10.1053\/j.gastro.2021.04.034_bib82","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.cgh.2007.02.035","article-title":"Immune response to influenza vaccine in pediatric patients with inflammatory bowel disease","volume":"5","author":"Mamula","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2021.04.034_bib83","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/ajg.2008.120","article-title":"Immune response to influenza vaccine in children with inflammatory bowel disease","volume":"104","author":"Lu","year":"2009","journal-title":"Am J Gastroenterol"},{"issue":"Suppl 5","key":"10.1053\/j.gastro.2021.04.034_bib84","doi-asserted-by":"crossref","first-page":"F1","DOI":"10.1016\/j.vaccine.2015.10.080","article-title":"The safety of influenza vaccines in children: An Institute for Vaccine Safety white paper","volume":"33","author":"Halsey","year":"2015","journal-title":"Vaccine"},{"key":"10.1053\/j.gastro.2021.04.034_bib85","doi-asserted-by":"crossref","first-page":"e1811","DOI":"10.1542\/peds.2012-3567","article-title":"Safety and utilization of influenza immunization in children with inflammatory bowel disease","volume":"131","author":"Benchimol","year":"2013","journal-title":"Pediatrics"},{"key":"10.1053\/j.gastro.2021.04.034_bib86","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6803a1","article-title":"Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices - United States, 2019-20 influenza season","volume":"68","author":"Grohskopf","year":"2019","journal-title":"MMWR Recomm Rep"},{"key":"10.1053\/j.gastro.2021.04.034_bib87","doi-asserted-by":"crossref","first-page":"647","DOI":"10.2165\/11599130-000000000-00000","article-title":"Economic evaluations of childhood influenza vaccination: a critical review","volume":"30","author":"Newall","year":"2012","journal-title":"Pharmacoeconomics"},{"key":"10.1053\/j.gastro.2021.04.034_bib88","first-page":"CD001269","article-title":"Vaccines for preventing influenza in healthy adults","volume":"2","author":"Demicheli","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1053\/j.gastro.2021.04.034_bib89","first-page":"CD004876","article-title":"Vaccines for preventing influenza in the elderly","volume":"2","author":"Demicheli","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1053\/j.gastro.2021.04.034_bib90","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1001\/archinte.160.21.3243","article-title":"Clinical signs and symptoms predicting influenza infection","volume":"160","author":"Monto","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1053\/j.gastro.2021.04.034_bib91","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1093\/ecco-jcc\/jjv152","article-title":"Immunogenicity and safety of influenza vaccine in inflammatory bowel disease patients treated or not with immunomodulators and\/or biologics: a two-year prospective study","volume":"9","author":"Launay","year":"2015","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1053\/j.gastro.2021.04.034_bib92","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.crohns.2013.08.008","article-title":"Infliximab and\/or immunomodulators inhibit immune responses to trivalent influenza vaccination in adults with inflammatory bowel disease","volume":"8","author":"Hagihara","year":"2014","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1053\/j.gastro.2021.04.034_bib93","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.crohns.2012.05.011","article-title":"Immune response to influenza A\/H1N1 vaccine in inflammatory bowel disease patients treated with anti TNF-alpha agents: effects of combined therapy with immunosuppressants","volume":"7","author":"Andrisani","year":"2013","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1053\/j.gastro.2021.04.034_bib94","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1136\/gutjnl-2011-300256","article-title":"Serological response to the 2009 H1N1 influenza vaccination in patients with inflammatory bowel disease","volume":"61","author":"Cullen","year":"2012","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2021.04.034_bib95","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1136\/ard.2007.077552","article-title":"The effect of anti-tumour necrosis factor alpha treatment on the antibody response to influenza vaccination","volume":"67","author":"Gelinck","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1053\/j.gastro.2021.04.034_bib96","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1136\/gut.2010.233981","article-title":"H1N1 vaccines in a large observational cohort of patients with inflammatory bowel disease treated with immunomodulators and biological therapy","volume":"60","author":"Rahier","year":"2011","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2021.04.034_bib97","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1093\/ibd\/izx101","article-title":"Immunogenicity of quadrivalent influenza vaccine for patients with inflammatory bowel disease undergoing immunosuppressive therapy","volume":"24","author":"Shirai","year":"2018","journal-title":"Inflamm Bowel Dis"},{"key":"10.1053\/j.gastro.2021.04.034_bib98","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1097\/MIB.0000000000000615","article-title":"Immunogenicity of influenza vaccine for patients with inflammatory bowel disease on maintenance infliximab therapy: a randomized trial","volume":"22","author":"deBruyn","year":"2016","journal-title":"Inflamm Bowel Dis"},{"key":"10.1053\/j.gastro.2021.04.034_bib99","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1007\/s00535-015-1042-7","article-title":"Booster influenza vaccination does not improve immune response in adult inflammatory bowel disease patients treated with immunosuppressives: a randomized controlled trial","volume":"50","author":"Matsumoto","year":"2015","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1053\/j.gastro.2021.04.034_bib100","doi-asserted-by":"crossref","first-page":"174","DOI":"10.3109\/00365521.2014.928902","article-title":"Antibody and cell-mediated immune response to whole virion and split virion influenza vaccine in patients with inflammatory bowel disease on maintenance immunosuppressive and biological therapy","volume":"50","author":"Balint","year":"2015","journal-title":"Scand J Gastroenterol"},{"key":"10.1053\/j.gastro.2021.04.034_bib101","doi-asserted-by":"crossref","first-page":"105734","DOI":"10.1016\/j.ypmed.2019.05.022","article-title":"A\u00a0review of the cost-effectiveness of adult influenza vaccination and other preventive services","volume":"126","author":"Dabestani","year":"2019","journal-title":"Prev Med"},{"key":"10.1053\/j.gastro.2021.04.034_bib102","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.tmaid.2018.05.016","article-title":"Incidence of invasive pneumococcal disease in immunocompromised patients: a systematic review and meta-analysis","volume":"24","author":"van Aalst","year":"2018","journal-title":"Travel Med Infect Dis"},{"key":"10.1053\/j.gastro.2021.04.034_bib103","doi-asserted-by":"crossref","first-page":"ofu024","DOI":"10.1093\/ofid\/ofu024","article-title":"Rates of pneumococcal disease in adults with chronic medical conditions","volume":"1","author":"Shea","year":"2014","journal-title":"Open Forum Infect Dis"},{"key":"10.1053\/j.gastro.2021.04.034_bib104","doi-asserted-by":"crossref","DOI":"10.1038\/ajg.2015.284","article-title":"Inflammatory bowel disease patients are at increased risk of invasive pneumococcal disease: a nationwide danish cohort study 1977-2013","volume":"110","author":"Kantso","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2021.04.034_bib105","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1136\/jech-2011-200168","article-title":"Risk of invasive pneumococcal disease in people admitted to hospital with selected immune-mediated diseases: record linkage cohort analyses","volume":"66","author":"Wotton","year":"2012","journal-title":"J\u00a0Epidemiol Community Health"},{"key":"10.1053\/j.gastro.2021.04.034_bib106","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/ajg.2012.406","article-title":"Increased risk of pneumonia among patients with inflammatory bowel disease","volume":"108","author":"Long","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2021.04.034_bib107","first-page":"CD004977","article-title":"Pneumococcal conjugate vaccines for preventing vaccine-type invasive pneumococcal disease and x-ray defined pneumonia in children less than two years of age","author":"Lucero","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1053\/j.gastro.2021.04.034_bib108","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1097\/MIB.0000000000000406","article-title":"Immunogenicity of 13-valent pneumococcal conjugate vaccine in pediatric patients with inflammatory bowel disease","volume":"21","author":"Banaszkiewicz","year":"2015","journal-title":"Inflamm Bowel Dis"},{"key":"10.1053\/j.gastro.2021.04.034_bib109","doi-asserted-by":"crossref","first-page":"24","DOI":"10.5009\/gnl.2014.8.1.24","article-title":"Evaluation of antibody response to polysaccharide vaccine and switched memory B cells in pediatric patients with inflammatory bowel disease","volume":"8","author":"Fallahi","year":"2014","journal-title":"Gut Liver"},{"key":"10.1053\/j.gastro.2021.04.034_bib110","first-page":"CD001480","article-title":"Pneumococcal conjugate vaccines for preventing acute otitis media in children","volume":"5","author":"Fortanier","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1053\/j.gastro.2021.04.034_bib112","doi-asserted-by":"crossref","first-page":"e58","DOI":"10.1016\/S2214-109X(18)30422-4","article-title":"Effect and cost-effectiveness of pneumococcal conjugate vaccination: a global modelling analysis","volume":"7","author":"Chen","year":"2019","journal-title":"Lancet Glob Health"},{"key":"10.1053\/j.gastro.2021.04.034_bib113","first-page":"CD000422","article-title":"Vaccines for preventing pneumococcal infection in adults","author":"Moberley","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1053\/j.gastro.2021.04.034_bib114","doi-asserted-by":"crossref","first-page":"e417","DOI":"10.1097\/MD.0000000000000417","article-title":"Pneumococcal vaccination rates in VHA patients with inflammatory bowel disease","volume":"94","author":"Case","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"10.1053\/j.gastro.2021.04.034_bib115","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1093\/cid\/ciz226","article-title":"Immunogenicity of the currently recommended pneumococcal vaccination schedule in patients with inflammatory bowel disease","volume":"70","author":"van Aalst","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1053\/j.gastro.2021.04.034_bib116","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.crohns.2013.09.022","article-title":"Patients with Crohn's disease on anti-tumor necrosis factor therapy are at significant risk of inadequate response to the 23-valent pneumococcal polysaccharide vaccine","volume":"8","author":"Lee","year":"2014","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1053\/j.gastro.2021.04.034_bib117","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1002\/ibd.21800","article-title":"Effects of immunosuppression on immune response to pneumococcal vaccine in inflammatory bowel disease: a prospective study","volume":"18","author":"Fiorino","year":"2012","journal-title":"Inflamm Bowel Dis"},{"key":"10.1053\/j.gastro.2021.04.034_bib118","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/ajg.2009.523","article-title":"Immunosuppression impairs response to pneumococcal polysaccharide vaccination in patients with inflammatory bowel disease","volume":"105","author":"Melmed","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2021.04.034_bib119","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.autrev.2018.08.002","article-title":"Immunogenicity, safety and tolerability of anti-pneumococcal vaccination in systemic lupus erythematosus patients: an evidence-informed and PRISMA compliant systematic review and meta-analysis","volume":"18","author":"Adawi","year":"2019","journal-title":"Autoimmun Rev"},{"key":"10.1053\/j.gastro.2021.04.034_bib120","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1186\/s12879-018-3326-z","article-title":"Clinical and economic burden of pneumococcal disease in US adults aged 19-64 years with chronic or immunocompromising diseases: an observational database study","volume":"18","author":"Zhang","year":"2018","journal-title":"BMC Infect Dis"},{"key":"10.1053\/j.gastro.2021.04.034_bib121","doi-asserted-by":"crossref","first-page":"3950","DOI":"10.1016\/j.vaccine.2013.06.037","article-title":"Cost-effectiveness of pneumococcal conjugate vaccination in immunocompromised adults","volume":"31","author":"Smith","year":"2013","journal-title":"Vaccine"},{"key":"10.1053\/j.gastro.2021.04.034_bib122","doi-asserted-by":"crossref","first-page":"6011","DOI":"10.1016\/j.vaccine.2013.10.024","article-title":"Cost-effectiveness\u00a0of administering 13-valent pneumococcal conjugate vaccine in addition to 23-valent pneumococcal polysaccharide vaccine to adults with immunocompromising conditions","volume":"31","author":"Cho","year":"2013","journal-title":"Vaccine"},{"key":"10.1053\/j.gastro.2021.04.034_bib123","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/BF02953677","article-title":"Hyposplenism in inflammatory bowel disease","volume":"157","author":"Rameh","year":"1988","journal-title":"Ir J Med Sci"},{"key":"10.1053\/j.gastro.2021.04.034_bib124","first-page":"333","article-title":"Splenic function in inflammatory bowel disease: assessment by differential interference microscopy and splenic ultrasound","volume":"86","author":"Muller","year":"1993","journal-title":"Q\u00a0J Med"},{"key":"10.1053\/j.gastro.2021.04.034_bib125","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1136\/gut.19.1.50","article-title":"Hyposplenism in inflammatory bowel disease","volume":"19","author":"Ryan","year":"1978","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2021.04.034_bib126","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S0140-6736(74)91695-X","article-title":"Hyposplenism in ulcerative colitis","volume":"2","author":"Ryan","year":"1974","journal-title":"Lancet"},{"key":"10.1053\/j.gastro.2021.04.034_bib127","first-page":"463","article-title":"Further experience of hyposplenism in inflammatory bowel disease","volume":"50","author":"Palmer","year":"1981","journal-title":"Q\u00a0J Med"},{"key":"10.1053\/j.gastro.2021.04.034_bib128","doi-asserted-by":"crossref","first-page":"717","DOI":"10.3109\/00313028109086645","article-title":"Splenic phagocytic function in patients with inflammatory bowel disease","volume":"13","author":"Jewell","year":"1981","journal-title":"Pathology"},{"key":"10.1053\/j.gastro.2021.04.034_bib129","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1111\/j.1572-0241.2005.41939.x","article-title":"Depletion of immunoglobulin M memory B cells is associated with splenic hypofunction in inflammatory bowel disease","volume":"100","author":"Di Sabatino","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2021.04.034_bib130","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S0140-6736(10)61493-6","article-title":"Post-splenectomy and hyposplenic states","volume":"378","author":"Di Sabatino","year":"2011","journal-title":"Lancet"},{"key":"10.1053\/j.gastro.2021.04.034_bib131","first-page":"36","article-title":"Fulminant meningococcal sepsis in a woman with previously unknown hyposplenism","volume":"10","author":"Shah","year":"2008","journal-title":"Medscape J Med"},{"key":"10.1053\/j.gastro.2021.04.034_bib132","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1016\/j.crohns.2012.06.012","article-title":"Meningococcal meningoencephalitis after certolizumab pegol treatment in a patient with Crohn's disease","volume":"7","author":"Majumder","year":"2013","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1053\/j.gastro.2021.04.034_bib133","first-page":"CD001093","article-title":"Polysaccharide vaccines for preventing serogroup A meningococcal meningitis","author":"Patel","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1053\/j.gastro.2021.04.034_bib134","series-title":"Conjugate vaccines for preventing meningococcal C meningitis and septicaemia","first-page":"CD001834","author":"Conterno","year":"2006"},{"key":"10.1053\/j.gastro.2021.04.034_bib136","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1542\/peds.2004-2514","article-title":"Cost-effectiveness of conjugate meningococcal vaccination strategies in the United States","volume":"115","author":"Shepard","year":"2005","journal-title":"Pediatrics"},{"key":"10.1053\/j.gastro.2021.04.034_bib137","doi-asserted-by":"crossref","first-page":"5436","DOI":"10.1016\/j.vaccine.2014.07.096","article-title":"Economic evaluation of meningococcal serogroup B childhood vaccination in Ontario, Canada","volume":"32","author":"Tu","year":"2014","journal-title":"Vaccine"},{"key":"10.1053\/j.gastro.2021.04.034_bib138","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.amepre.2018.09.020","article-title":"Cost-effectiveness of meningococcal serogroup b vaccination in college-aged young adults","volume":"56","author":"Leeds","year":"2019","journal-title":"Am J Prev Med"},{"key":"10.1053\/j.gastro.2021.04.034_bib139","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1097\/QAI.0000000000000822","article-title":"Cost-effectiveness of meningococcal vaccination among men who have sex with men in New York City","volume":"71","author":"Simon","year":"2016","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"key":"10.1053\/j.gastro.2021.04.034_bib140","doi-asserted-by":"crossref","first-page":"160","DOI":"10.14745\/ccdr.v40i09a01","article-title":"Enhanced surveillance of invasive meningococcal disease in Canada, 2006-2011","volume":"40","author":"Li","year":"2014","journal-title":"Can Commun Dis Rep"},{"key":"10.1053\/j.gastro.2021.04.034_bib141","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1080\/14760584.2017.1258308","article-title":"The Global Meningococcal Initiative: global epidemiology, the impact of vaccines on meningococcal disease and the importance of herd protection","volume":"16","author":"Borrow","year":"2017","journal-title":"Expert Rev Vaccines"},{"key":"10.1053\/j.gastro.2021.04.034_bib142","doi-asserted-by":"crossref","first-page":"6309","DOI":"10.1016\/j.vaccine.2016.10.049","article-title":"Long-term persistence of protective antibodies in Dutch adolescents following a meningococcal serogroup C tetanus booster vaccination","volume":"34","author":"van Ravenhorst","year":"2016","journal-title":"Vaccine"},{"key":"10.1053\/j.gastro.2021.04.034_bib143","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1056\/NEJMoa1900236","article-title":"Meningococcal B vaccine and meningococcal carriage in adolescents in Australia","volume":"382","author":"Marshall","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1053\/j.gastro.2021.04.034_bib144","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1093\/cid\/civ028","article-title":"Outcomes of invasive meningococcal disease in adults and children in Canada between 2002 and 2011: a prospective cohort study","volume":"60","author":"Sadarangani","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1053\/j.gastro.2021.04.034_bib145","author":"Faulkner"},{"key":"10.1053\/j.gastro.2021.04.034_bib146","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6702a1","article-title":"Prevention of pertussis, tetanus, and diphtheria with vaccines in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"67","author":"Liang","year":"2018","journal-title":"MMWR Recomm Rep"},{"key":"10.1053\/j.gastro.2021.04.034_bib147","first-page":"CD001478","article-title":"Acellular vaccines for preventing whooping cough in children","author":"Zhang","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1053\/j.gastro.2021.04.034_bib148","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1097\/MIB.0000000000001076","article-title":"Immunogenicity of pertussis booster vaccination in children and adolescents with inflammatory bowel disease: a controlled study","volume":"23","author":"Banaszkiewicz","year":"2017","journal-title":"Inflamm Bowel Dis"},{"key":"10.1053\/j.gastro.2021.04.034_bib149","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1097\/MIB.0000000000000448","article-title":"Combined immunosuppression impairs immunogenicity to tetanus and pertussis vaccination among patients with inflammatory bowel disease","volume":"21","author":"Dezfoli","year":"2015","journal-title":"Inflamm Bowel Dis"},{"key":"10.1053\/j.gastro.2021.04.034_bib150","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1080\/003655201750074537","article-title":"Increased levels of specific leukocyte- and platelet-derived substances during normal anti-tetanus antibody synthesis in patients with inactive Crohn disease","volume":"36","author":"Nielsen","year":"2001","journal-title":"Scand J Gastroenterol"},{"key":"10.1053\/j.gastro.2021.04.034_bib151","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1007\/s10620-018-5043-2","article-title":"Lower sustained diphtheria and pertussis antibody concentrations in inflammatory bowel disease patients","volume":"63","author":"Caldera","year":"2018","journal-title":"Dig Dis Sci"},{"key":"10.1053\/j.gastro.2021.04.034_bib152","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2017-4171","article-title":"Safety surveillance of diphtheria and tetanus toxoids and acellular pertussis (DTaP) vaccines","volume":"142","author":"Moro","year":"2018","journal-title":"Pediatrics"},{"key":"10.1053\/j.gastro.2021.04.034_bib153","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1542\/peds.2013-0698","article-title":"Economic evaluation of the routine childhood immunization program in the United States, 2009","volume":"133","author":"Zhou","year":"2014","journal-title":"Pediatrics"},{"key":"10.1053\/j.gastro.2021.04.034_bib154","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1001\/archpedi.154.8.797","article-title":"Economic evaluation of use of diphtheria, tetanus, and acellular pertussis vaccine or diphtheria, tetanus, and whole-cell pertussis vaccine in the United States, 1997","volume":"154","author":"Ekwueme","year":"2000","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1053\/j.gastro.2021.04.034_bib155","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12879-018-2967-2","article-title":"Cost-effectiveness of increasing vaccination in high-risk adults aged 18-64 years: a model-based decision analysis","volume":"18","author":"Wateska","year":"2018","journal-title":"BMC Infect Dis"},{"key":"10.1053\/j.gastro.2021.04.034_bib156","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1097\/MIB.0000000000000338","article-title":"Are patients with inflammatory bowel disease on chronic immunosuppressive therapy at increased risk of cervical high-grade dysplasia\/cancer? A meta-analysis","volume":"21","author":"Allegretti","year":"2015","journal-title":"Inflamm Bowel Dis"},{"key":"10.1053\/j.gastro.2021.04.034_bib157","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1093\/ecco-jcc\/jjx040","article-title":"Cancer risk in the early stages of inflammatory bowel disease in Korean patients: a nationwide population-based study","volume":"11","author":"Jung","year":"2017","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1053\/j.gastro.2021.04.034_bib158","doi-asserted-by":"crossref","first-page":"E711","DOI":"10.1002\/ijc.29209","article-title":"Risk of cervical cancer in women with autoimmune diseases, in relation with their use of immunosuppressants and screening: population-based cohort study","volume":"136","author":"Dugue","year":"2015","journal-title":"Int J Cancer"},{"key":"10.1053\/j.gastro.2021.04.034_bib159","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1038\/ajg.2013.249","article-title":"Cancer risk in inflammatory bowel disease according to patient phenotype and treatment: a Danish population-based cohort study","volume":"108","author":"Jess","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2021.04.034_bib160","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/1097-0142(20010215)91:4<854::AID-CNCR1073>3.0.CO;2-Z","article-title":"Cancer risk in patients with inflammatory bowel disease: a population-based study","volume":"91","author":"Bernstein","year":"2001","journal-title":"Cancer"},{"key":"10.1053\/j.gastro.2021.04.034_bib161","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.suronc.2013.08.002","article-title":"A\u00a0systematic review of anal squamous cell carcinoma in inflammatory bowel disease","volume":"22","author":"Slesser","year":"2013","journal-title":"Surg Oncol"},{"key":"10.1053\/j.gastro.2021.04.034_bib162","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1097\/MIB.0b013e318281341b","article-title":"Immunogenicity and tolerability to human papillomavirus-like particle vaccine in girls and young women with inflammatory bowel disease","volume":"19","author":"Jacobson","year":"2013","journal-title":"Inflamm Bowel Dis"},{"key":"10.1053\/j.gastro.2021.04.034_bib163","doi-asserted-by":"crossref","first-page":"715","DOI":"10.2165\/11599470-000000000-00000","article-title":"The cost effectiveness of human papillomavirus vaccines: a systematic review","volume":"72","author":"Seto","year":"2012","journal-title":"Drugs"},{"key":"10.1053\/j.gastro.2021.04.034_bib164","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1186\/1471-2458-14-700","article-title":"Barriers and facilitators to HPV vaccination of young women in high-income countries: a qualitative systematic review and evidence synthesis","volume":"14","author":"Ferrer","year":"2014","journal-title":"BMC Public Health"},{"key":"10.1053\/j.gastro.2021.04.034_bib165","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1001\/jamapediatrics.2013.2752","article-title":"Barriers to human papillomavirus vaccination among US adolescents: a systematic review of the literature","volume":"168","author":"Holman","year":"2014","journal-title":"JAMA Pediatr"},{"key":"10.1053\/j.gastro.2021.04.034_bib166","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.crohns.2013.12.013","article-title":"Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease","volume":"8","author":"Rahier","year":"2014","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1053\/j.gastro.2021.04.034_bib167","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/ajg.2016.537","article-title":"ACG clinical guideline: preventive care in inflammatory bowel disease","volume":"112","author":"Farraye","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2021.04.034_bib168","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/jcag\/gwaa046","article-title":"COVID-19 Vaccination in patients with inflammatory bowel disease: communiqu\u00e9 from the Canadian Association of Gastroenterology","volume":"4","author":"Tse","year":"2021","journal-title":"J Can Assoc Gastroenterol"}],"container-title":["Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508521006582?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508521006582?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T15:35:31Z","timestamp":1758036931000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0016508521006582"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":163,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["S0016508521006582"],"URL":"https:\/\/doi.org\/10.1053\/j.gastro.2021.04.034","relation":{},"ISSN":["0016-5085"],"issn-type":[{"value":"0016-5085","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Canadian Association of Gastroenterology Clinical Practice Guideline for Immunizations in Patients With Inflammatory Bowel Disease (IBD)\u2014Part 2: Inactivated Vaccines","name":"articletitle","label":"Article Title"},{"value":"Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.gastro.2021.04.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 by the AGA Institute and the Canadian Association of Gastroenterology. This article is being published jointly in Gastroenterology and Journal of the Canadian Association of Gastroenterology.","name":"copyright","label":"Copyright"}]}}